185 related articles for article (PubMed ID: 38438481)
1. Recurrent UBE3C-LRP5 translocations in head and neck cancer with therapeutic implications.
Dharavath B; Butle A; Chaudhary A; Pal A; Desai S; Chowdhury A; Thorat R; Upadhyay P; Nair S; Dutt A
NPJ Precis Oncol; 2024 Mar; 8(1):63. PubMed ID: 38438481
[TBL] [Abstract][Full Text] [Related]
2. UBE3C promotes proliferation and inhibits apoptosis by activating the β-catenin signaling via degradation of AXIN1 in gastric cancer.
Zhang Y; Xu J; Fu H; Wei Z; Yang D; Yan R
Carcinogenesis; 2021 Feb; 42(2):285-293. PubMed ID: 32930707
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling.
Hang C; Zhao S; Wang T; Zhang Y
Cancer Cell Int; 2021 Jan; 21(1):25. PubMed ID: 33407510
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of pyrvinium pamoate on uveal melanoma cells involves blocking of Wnt/β-catenin pathway.
Zheng L; Liu Y; Pan J
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):890-898. PubMed ID: 28981601
[TBL] [Abstract][Full Text] [Related]
5. UBE3C promotes growth and metastasis of renal cell carcinoma via activating Wnt/β-catenin pathway.
Wen JL; Wen XF; Li RB; Jin YC; Wang XL; Zhou L; Chen HX
PLoS One; 2015; 10(2):e0115622. PubMed ID: 25658088
[TBL] [Abstract][Full Text] [Related]
6. LRP5 knockdown: effect on prostate cancer invasion growth and skeletal metastasis in vitro and in vivo.
Rabbani SA; Arakelian A; Farookhi R
Cancer Med; 2013 Oct; 2(5):625-35. PubMed ID: 24403228
[TBL] [Abstract][Full Text] [Related]
7. An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/beta-catenin signaling.
Björklund P; Akerström G; Westin G
PLoS Med; 2007 Nov; 4(11):e328. PubMed ID: 18044981
[TBL] [Abstract][Full Text] [Related]
8. LRP5 Promotes Gastric Cancer via Activating Canonical Wnt/β-Catenin and Glycolysis Pathways.
Nie X; Wang H; Wei X; Li L; Xue T; Fan L; Ma H; Xia Y; Wang YD; Chen WD
Am J Pathol; 2022 Mar; 192(3):503-517. PubMed ID: 34896072
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells.
Kleszcz R; Szymańska A; Krajka-Kuźniak V; Baer-Dubowska W; Paluszczak J
Cell Oncol (Dordr); 2019 Aug; 42(4):505-520. PubMed ID: 31089983
[TBL] [Abstract][Full Text] [Related]
10. Induction of LEF1 by MYC activates the WNT pathway and maintains cell proliferation.
Hao YH; Lafita-Navarro MC; Zacharias L; Borenstein-Auerbach N; Kim M; Barnes S; Kim J; Shay J; DeBerardinis RJ; Conacci-Sorrell M
Cell Commun Signal; 2019 Oct; 17(1):129. PubMed ID: 31623618
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the Wnt/β-Catenin signaling pathway in the heterogenous nuclear ribonucleoprotein K-driven inhibition of proliferation and migration in head and neck squamous cell carcinoma.
Liu H; Chen X; Yang X; Li M; Zhang W; Zhang G; Zhan X; Cao L; Li W; Huang Z; Gao R
Oncol Lett; 2020 Dec; 20(6):394. PubMed ID: 33193854
[TBL] [Abstract][Full Text] [Related]
12. Normal hematopoiesis and lack of β-catenin activation in osteoblasts of patients and mice harboring Lrp5 gain-of-function mutations.
Galán-Díez M; Isa A; Ponzetti M; Nielsen MF; Kassem M; Kousteni S
Biochim Biophys Acta; 2016 Mar; 1863(3):490-498. PubMed ID: 26681532
[TBL] [Abstract][Full Text] [Related]
13. Deletion of low-density lipoprotein-related receptor 5 inhibits liver Cancer cell proliferation via destabilizing Nucleoporin 37.
Chen J; Wo D; Ma E; Yan H; Peng J; Zhu W; Fang Y; Ren DN
Cell Commun Signal; 2019 Dec; 17(1):174. PubMed ID: 31881970
[TBL] [Abstract][Full Text] [Related]
14. Possible repurposing of pyrvinium pamoate for the treatment of mesothelioma: A pre-clinical assessment.
Barbarino M; Cesari D; Intruglio R; Indovina P; Namagerdi A; Bertolino FM; Bottaro M; Rahmani D; Bellan C; Giordano A
J Cell Physiol; 2018 Sep; 233(9):7391-7401. PubMed ID: 29659015
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of Wnt-LRP5 signaling suppresses the proliferation and migration of ovarian cancer cells.
Hong J; Xie Z; Yang Z; Yang F; Liao H; Rao S; Huang X
Transl Cancer Res; 2021 May; 10(5):2277-2285. PubMed ID: 35116545
[TBL] [Abstract][Full Text] [Related]
16. Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling.
Sun X; Li K; Hase M; Zha R; Feng Y; Li BY; Yokota H
Theranostics; 2022; 12(2):929-943. PubMed ID: 34976221
[No Abstract] [Full Text] [Related]
17. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Lrp5 enhanced the anti-breast cancer effects of osteocytes in bone.
Liu S; Wu D; Sun X; Fan Y; Zha R; Jalali A; Feng Y; Li K; Sano T; Vike N; Li F; Rispoli J; Sudo A; Liu J; Robling A; Nakshatri H; Li BY; Yokota H
Bone Res; 2021 Jul; 9(1):32. PubMed ID: 34230453
[TBL] [Abstract][Full Text] [Related]
19. Peptide-based mediated disruption of N-cadherin-LRP5/6 interaction promotes Wnt signaling and bone formation.
Haÿ E; Buczkowski T; Marty C; Da Nascimento S; Sonnet P; Marie PJ
J Bone Miner Res; 2012 Sep; 27(9):1852-63. PubMed ID: 22576936
[TBL] [Abstract][Full Text] [Related]
20. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.
Zhang C; Zhang Z; Zhang S; Wang W; Hu P
Med Sci Monit; 2017 Jan; 23():266-275. PubMed ID: 28090074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]